Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02454842
Title Study for Treatment of Patients With EGFR Mutant, T790M-negative NSCLC
Acronym TH-4000
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Threshold Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of Southern California-Norris Los Angeles California 90033 United States Details
St. Joseph Heritage Healthcare Santa Rosa California 95403 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Walter Reed National Military Medical Center Bethesda Maryland 20889 United States Details
University of North Carolina Lineberger Cancer Center Chapel Hill North Carolina 27514 United States Details
University of Pennsylvania-Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt-Ingram Cancer Center (VICC) Nashville Tennessee 37232 United States Details
UT Southwestern Medical Center Dallas Texas 75235 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
Peter MacCullum Melbourne Victoria 3002 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field